Home
/ Canixa
/ Competitors

Canixa Competitors and Similar CompaniesClear all

Canixa's competitors and similar companies include Evofem Biosciences, Revance Therapeutics and Anika Therapeutics.

	Canixa Canixa is a healthcare company that provides medicinal products.	Evofem Biosciences Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.	Revance Therapeutics Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings.	Anika Therapeutics Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair.
Founding Date	Founding Date 2008	Founding Date 2007	Founding Date 2002	Founding Date 1992
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare drug development health & beauty	Tags Healthcare biotech drug development health & beauty	Tags Healthcare biotech drug development health & beauty	Tags Healthcare biotech drug development health & beauty
Locations	Locations New Delhi, IN HQ Bengaluru, IN Cuttack, IN Raipur, IN	Locations San Diego, US HQ	Locations Nashville, US HQ Irvine, US Newark, US Pleasanton, US	Locations Bedford, US HQ Padova, IT Padova, IT Franklin, US
Employees	Employees N/A	Employees 3030% increase	Employees 59712% increase	Employees 15416% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.2 m	Valuation ($) 615.7 m	Valuation ($) 365 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $20.2m (FY, 2025)	Revenue (est.) $234m (FY, 2023)	Revenue (est.) $112.8m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $4.6m (FY, 2025)	Cost of goods $74.4m (FY, 2023)	Cost of goods $49m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $15.6m (FY, 2025)	Gross profit $159.7m (FY, 2023)	Gross profit $63.8m (FY, 2025)
Net income	Net income N/A	Net income $391k (FY, 2025)	Net income ($324m) (FY, 2023)	Net income ($10.9m) (FY, 2025)